This report was sent to Briefing.com subscribers earlier today.
Research calls posted earlier this morning are available here.
Upgrades:
> Fortive (FTV) upgraded to Buy from Hold at Vertical Research; tgt $74
> HeidelbergCement (HDELY) upgraded to Buy from Hold at Jefferies
> J.M. Smucker (SJM) upgraded to Buy from Hold at Argus; tgt $170
> Renault (RNSDF) upgraded to Buy from Hold at HSBC Securities
Downgrades:
> Berkshire Grey (BGRY) downgraded to Hold from Buy at Craig Hallum; tgt lowered to $1.40
> CyberAgent (CYGIY) downgraded to Sell from Neutral at Citigroup
> Pernod-Ricard (PDRDY) downgraded to Neutral from Overweight at JP Morgan
> Roche Hldg (RHHBY) downgraded to Equal Weight from Overweight at Barclays
Others:
> Autolus Therapeutics (AUTL) assumed with an Overweight at Wells Fargo; tgt $8
> Fate Therapeutics (FATE) assumed with an Equal Weight at Wells Fargo; tgt $6
> FedEx (FDX) initiated with a Hold at Melius; tgt $240
> Fisker (FSR) placed on Catalyst Watch at Citigroup
> Gracell Biotechnologies (GRCL) assumed with an Overweight at Wells Fargo; tgt $7
> Iovance Biotherapeutics (IOVA) assumed with an Equal Weight at Wells Fargo; tgt $11
> Lion Electric (LEV) initiated with a Buy at R. F. Lafferty; tgt $7
> UPS (UPS) initiated with a Buy at Melius; tgt $225
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.